Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea
· Delayed Price · Currency is KRW 5,170.00
+190.00 (3.82%)
Feb 21, 2025, 9:00 AM KST
Korean Drug Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 56,415 | 78,348 | 85,441 | 97,444 | 112,394 | 78,457 | Upgrade
|
| Market Cap Growth | -23.28% | -8.30% | -12.32% | -13.30% | 43.25% | -0.42% | Upgrade
|
| Enterprise Value | 36,361 | 41,605 | 53,950 | 71,749 | 92,548 | 67,689 | Upgrade
|
| Last Close Price | 5170.00 | 6950.85 | 7420.19 | 8273.15 | 9360.52 | 6437.63 | Upgrade
|
| PE Ratio | - | - | 7.24 | 10.78 | 15.27 | 20.14 | Upgrade
|
| PS Ratio | 0.75 | 0.96 | 1.07 | 1.31 | 1.68 | 1.41 | Upgrade
|
| PB Ratio | 0.69 | 1.02 | 1.01 | 1.27 | 1.59 | 1.21 | Upgrade
|
| P/TBV Ratio | 0.68 | 1.02 | 1.01 | 1.27 | 1.60 | 1.22 | Upgrade
|
| P/FCF Ratio | - | - | - | 12.72 | 9.70 | 24.86 | Upgrade
|
| P/OCF Ratio | - | - | 14.45 | 11.07 | 9.12 | 12.64 | Upgrade
|
| EV/Sales Ratio | 0.49 | 0.51 | 0.67 | 0.96 | 1.39 | 1.22 | Upgrade
|
| EV/EBITDA Ratio | 15.80 | 4.91 | 3.43 | 5.63 | 7.47 | 14.71 | Upgrade
|
| EV/EBIT Ratio | 147.11 | 6.19 | 3.77 | 6.37 | 8.38 | 19.81 | Upgrade
|
| EV/FCF Ratio | -2.44 | - | - | 9.37 | 7.98 | 21.45 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.01 | 0.00 | 0.03 | Upgrade
|
| Asset Turnover | 0.73 | 0.88 | 0.87 | 0.87 | 0.84 | 0.75 | Upgrade
|
| Inventory Turnover | 1.95 | 2.74 | 3.41 | 3.67 | 3.37 | 3.23 | Upgrade
|
| Quick Ratio | 4.56 | 4.52 | 7.81 | 5.51 | 5.13 | 4.62 | Upgrade
|
| Current Ratio | 6.87 | 6.41 | 9.80 | 6.82 | 6.44 | 6.15 | Upgrade
|
| Return on Equity (ROE) | -0.48% | -6.08% | 14.63% | 12.26% | 10.83% | 6.09% | Upgrade
|
| Return on Assets (ROA) | 0.15% | 4.56% | 9.78% | 8.19% | 8.67% | 2.87% | Upgrade
|
| Return on Capital (ROIC) | 0.19% | 5.19% | 11.09% | 9.54% | 10.14% | 3.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.30% | 8.42% | 16.45% | 14.39% | 15.00% | 5.08% | Upgrade
|
| Earnings Yield | -0.69% | -6.28% | 13.82% | 9.28% | 6.55% | 4.96% | Upgrade
|
| FCF Yield | -26.40% | -9.97% | -0.21% | 7.86% | 10.31% | 4.02% | Upgrade
|
| Payout Ratio | 0.00% | - | 15.52% | 18.07% | 14.80% | 27.99% | Upgrade
|
| Buyback Yield / Dilution | 0.75% | 0.01% | 1.25% | -0.46% | 0.37% | 0.07% | Upgrade
|
| Total Shareholder Return | 3.65% | 0.01% | 1.25% | -0.46% | 0.37% | 0.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.